Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Alberta Health Services
Edmonton, Canada
University of Oxford
Oxford, United Kingdom
University of Washington
Seattle, United States
The University of Osaka
Osaka, Japan
Inserm
Paris, France
University of California, San Francisco
San Francisco, United States
University Health Network
Toronto, Canada
Kobe University
Kobe, Japan
University of Tsukuba
Tsukuba, Japan
Shiga University of Medical Science
Ōtsu, Japan
References
References (37)
- 1
Clinical and morphological features of collagen type III glomerulopathy: a report of nine cases from a single institution.
Bao H, Chen H, Zhu X, et al.
Histopathology 2015; (67(4)):568-76 doi:10.1111/his.12685.
PMID: 25753597 - 2
Collagenofibrotic glomerulopathy.
Kurien AA, Larsen CP, Cossey LN
Clinical kidney journal 2015; (8(5)):543-7 doi:10.1093/ckj/sfv061.
PMID: 26413279 - 3
Clinical and histological findings of autosomal dominant renal-limited disease with LMX1B mutation.
Konomoto T, Imamura H, Orita M, et al.
Nephrology (Carlton, Vic.) 2016; (21(9)):765-73 doi:10.1111/nep.12666.
PMID: 26560070 - 4
Collagen type III glomerulopathy: A case report and review of 20 cases.
Dong J, Wei H, Han M, et al.
Experimental and therapeutic medicine 2015; (10(4)):1445-1449 doi:10.3892/etm.2015.2695.
PMID: 26622504 - 5
Type III collagen disorders: A case report and review of literature.
Anitha A, Vankalakunti M, Siddini V, et al.
Indian journal of pathology & microbiology 2016; (59(1)):75-7 doi:10.4103/0377-4929.174822.
PMID: 26960642 - 6
Pathophysiology and Clinical Work-Up of Acute Kidney Injury.
Meola M, Nalesso F, Petrucci I, et al.
Contributions to nephrology 2016; (188()):1-10 doi:10.1159/000445460.
PMID: 27169469 - 7
Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit.
Gaudry S, Hajage D, Schortgen F, et al.
The New England journal of medicine 2016; (375(2)):122-33 doi:10.1056/NEJMoa1603017.
PMID: 27181456 - 8
Collagen type III glomerulopathy: case report and review of the literature .
Chen X, Wang H, Xu W, Zhu J
Clinical nephrology 2017; (87 (2017)(1)):39-46 doi:10.5414/CN108907.
PMID: 27900943 - 9
Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults.
Kaddourah A, Basu RK, Bagshaw SM, et al.
The New England journal of medicine 2017; (376(1)):11-20 doi:10.1056/NEJMoa1611391.
PMID: 27959707 - 10
Unusual cause of glomerular deposition disease: Collagenofibrotic glomerulopathy.
Nimmagadda S, Mukku K, Devaraju SR, Uppin MS
Indian journal of nephrology 2017; (27(1)):62-65 doi:10.4103/0971-4065.179300.
PMID: 28182050 - 11
Collagenofibrotic (Collagen Type III) glomerulopathy in association with diabetic nephropathy.
Alsaad KO, Edrees B, Rahim KA, et al.
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2017; (28(4)):898-905.
PMID: 28748894 - 12
LMX1B-Associated Nephropathy With Type III Collagen Deposition in the Glomerular and Tubular Basement Membranes.
Andeen NK, Schleit J, Blosser CD, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2018; (72(2)):296-301 doi:10.1053/j.ajkd.2017.09.023.
PMID: 29246420 - 13
Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report.
Weir MR, Lakkis JI, Jaar B, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2018; (72(6)):873-884 doi:10.1053/j.ajkd.2018.06.010.
PMID: 30201547 - 14
Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis.
Barbar SD, Clere-Jehl R, Bourredjem A, et al.
The New England journal of medicine 2018; (379(15)):1431-1442 doi:10.1056/NEJMoa1803213.
PMID: 30304656 - 15
Disparate outcomes observed within Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury stage 1.
Sparrow HG, Swan JT, Moore LW, et al.
Kidney international 2019; (95(4)):905-913 doi:10.1016/j.kint.2018.11.030.
PMID: 30819553 - 16
Collagenofibrotic glomerulopathy - A rare disease diagnosed with the aid of transmission electron microscopy.
Matthai SM, Mohapatra A, Duhli N, et al.
Indian journal of pathology & microbiology 2020; (63(Supplement)):S47-S49 doi:10.4103/IJPM.IJPM_341_18.
PMID: 32108627 - 17
Collagenofibrotic glomerulopathy- report of a rare renal disease with serial biopsies.
Ng YF, Chow CY, Yang WS, et al.
The Malaysian journal of pathology 2020; (42(1)):131-135.
PMID: 32342943 - 18
Two cases of Type Ⅲ collagen glomerulopathy and literature review.
Yu F, Zhu X, Yuan S, et al.
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2020; (45(7)):869-873 doi:10.11817/j.issn.1672-7347.2020.190130.
PMID: 32879092 - 19
Collagenofibrotic Glomerulopathy.
Miyake M, Katayama K, Ehara T, et al.
Internal medicine (Tokyo, Japan) 2021; (60(6)):911-915 doi:10.2169/internalmedicine.6090-20.
PMID: 33055489 - 20
Telmisartan alleviates collagen type III glomerulopathy: A case report with literature review.
Guo Q, Liu L, Nie P, Luo P
Experimental and therapeutic medicine 2020; (20(6)):140 doi:10.3892/etm.2020.9269.
PMID: 33093878 - 21
Collagenofibrotic glomerulopathy in a kidney transplant recipient: A first report.
Jdiaa SS, Moeckel GW, Kfoury HM, et al.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2021; (21(5)):1948-1952 doi:10.1111/ajt.16399.
PMID: 33206467 - 22
LMX1B-associated nephropathy that showed myelin figures on electron microscopy.
Shimohata H, Miyake Y, Yoshida Y, et al.
CEN case reports 2021; (10(4)):588-591 doi:10.1007/s13730-021-00612-y.
PMID: 34076843 - 23
A Rare Cause of Nephrotic Syndrome in Adults - Collagenofibrotic Glomerulopathy.
Shenoy P, Divya J
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2021; (32(1)):223-226 doi:10.4103/1319-2442.318528.
PMID: 34145135 - 24
Two to Tango: Kidney-Lung Interaction in Acute Kidney Injury and Acute Respiratory Distress Syndrome.
Alge J, Dolan K, Angelo J, et al.
Frontiers in pediatrics 2021; (9()):744110 doi:10.3389/fped.2021.744110.
PMID: 34733809 - 25
Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria.
Chu CD, Powe NR, Estrella MM, et al.
Mayo Clinic proceedings 2022; (97(11)):2099-2106 doi:10.1016/j.mayocp.2022.07.010.
PMID: 36210196 - 26
The first case of lipoprotein glomerulopathy complicated with collagen type III glomerulopathy and literature review.
Liu H, Luo C, Li Z, et al.
Journal of nephrology 2023; (36(3)):663-667 doi:10.1007/s40620-022-01491-x.
PMID: 36370330 - 27
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
The lancet. Diabetes & endocrinology 2024; (12(1)):39-50 doi:10.1016/S2213-8587(23)00321-2.
PMID: 38061371 - 28
Simultaneous Occurrence of Collagen Type III Glomerulopathy and Immunoglobulin A Nephropathy: A Rare Case Report.
Aloudah NM, Moalwi SH, Alnofal WY
The American journal of case reports 2024; (25()):e942770 doi:10.12659/AJCR.942770.
PMID: 38662643 - 29
Excessive Initial Renal Function Decline Following Sodium-Glucose Cotransporter-2 Inhibitor Treatment Predicts Major Adverse Cardiorenal Outcomes.
Chen CY, Huang SS, Ou SM, et al.
Mayo Clinic proceedings 2025; (100(2)):204-219 doi:10.1016/j.mayocp.2024.08.028.
PMID: 39797864 - 30
Dapagliflozin for the Treatment of Collagenofibrotic Glomerulopathy.
Imai E, Imai A, Izumi M, et al.
Internal medicine (Tokyo, Japan) 2025; (64(17)):2615-2618 doi:10.2169/internalmedicine.4952-24.
PMID: 39971290 - 31
The essential role of electron microscopy in the diagnosis of collagen type III glomerulopathy superimposed with membranous nephropathy or diabetic nephropathy.
Zhang F, Shen Q, Sun X, et al.
BMC nephrology 2025; (26(1)):364 doi:10.1186/s12882-025-04315-9.
PMID: 40629285 - 32
Collagenofibrotic Glomerulopathy Associated With Homozygous STAB2 and Heterozygous STAB1 Variants: A Case Report.
Yamamoto S, Kaimori JY, Motooka D, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2026; (87(4)):592-596 doi:10.1053/j.ajkd.2025.10.016.
PMID: 41548739 - 33
[Broad cardiorenal protection with SGLT2 inhibitors : Evidence, indications and clinical practice].
Rawish E, Eitel I
Innere Medizin (Heidelberg, Germany) 2026; (67(6)):695-704 doi:10.1007/s00108-026-02098-1.
PMID: 41888417 - 34
Acute Estimated Glomerular Filtration Rate Decline After Initiation of Therapies That Slow Kidney Disease Progression: Clinical Practice Implications.
Cherney DZI, Alicic RZ, Bonaca MP
Mayo Clinic proceedings 2026; (101(8)):1347-1366 doi:10.1016/j.mayocp.2026.01.010.
PMID: 42017862 - 35
Collagenofibrotic Glomerulopathy With Concurrent Ostium Secundum Atrial Septal Defect and Anti-Ku Antibody Positivity: A Rare Case.
Thakare S, Kuthe SS, Shaikh FI, et al.
Cureus 2026; (18(7)):e112641 doi:10.7759/cureus.112641.
PMID: 42639453 - 36
Type III Collagen Glomerulopathy Presenting With Divergent Histopathological Patterns: Report of Two Adult Cases and Diagnostic Pitfalls.
Nili F, Abdollahi A, Arabmohammadi P, Salarvand S
Case reports in nephrology 2026; (2026()):6022775 doi:10.1155/crin/6022775.
PMID: 42775177 - 37
Four cases of type III collagen deposition glomerulopathy and summary of the literature.
Lin X, Xu Y, Lin X, et al.
International urology and nephrology 2026; doi:10.1007/s11255-026-05431-7.
PMID: 42859380